Chief Financial Officer & Secretary
Dave Lowrance made an average of $1.3M in compensation at Mast Therapeutics between 2017 and 2018.
In 2018, Dave Lowrance earned a total compensation of $2.2M as Chief Financial Officer & Secretary at Mast Therapeutics.
|Ranking||3,555 out of 8,692|
Dave Lowrance's 2018 compensation ranked 3,555th out of 8,692 executive pay records tracked by us this year.
Lowrance earned more than 59.1% of all executives tracked by us in 2018.
|Ranking||246 out of 614|
In the industry group of Drugs, Lowrance's pay ranked 246th out of 614 executive pay records tracked by us in 2018.
Lowrance earned more than 59.9% of executives in this group.
|Non-Equity Incentive Plan||$116,891|
Lowrance received $1.7M in option awards, which accounts for 76.84% of total compensation.
Lowrance also received $116.9K in non-equity incentive plan, $365K in salary and $22K in other compensation.
|Dave Lowrance's Pay||$2,175,253|
|Median Employee's Pay||$282,179|
|Pay Ratio||8 : 1|
For fiscal year 2018, the annual total compensation for Dave Lowrance was $2,175,253 and for the median employee at Mast Therapeutics was $282,179. The resulting ratio of Dave Lowrance's pay to the pay of median employee was 8 to one.
In 2017, Dave Lowrance earned a total compensation of $389.1K as Chief Financial Officer & Secretary at Mast Therapeutics.
|Ranking||11,489 out of 13,224|
Dave Lowrance's 2017 compensation ranked 11,489th out of 13,224 executive pay records tracked by us this year.
Lowrance earned more than 13.1% of all executives tracked by us in 2018.
|Ranking||1,256 out of 1,405|
In the industry group of Drugs, Lowrance's pay ranked 1,256th out of 1,405 executive pay records tracked by us in 2017.
Lowrance earned more than 10.6% of executives in this group.
|Non-Equity Incentive Plan||$90,750|
Lowrance received $204.3K in salary, which accounts for 52.50% of total compensation.
Lowrance also received $88.1K in bonus, $90.8K in non-equity incentive plan and $6K in other compensation.